YONGHE MED.GR.DL-0000025 Cash Flow-to-Debt Ratio
YONGHE MED.GR.DL-0000025 cash flow-to-debt ratio. YONGHE MED.GR.DL-0000025 (L97) has a Cash Flow-to-Debt Ratio of 0.54x as of December 2025, meaning its operating cash flow of €495.53 Million could theoretically repay 1% of its total liabilities (€914.47 Million) in one year. Check YONGHE MED.GR.DL-0000025 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of YONGHE MED.GR.DL-0000025 (2021–2025)
Cash flow-to-debt ratio of YONGHE MED.GR.DL-0000025 from 2021 to 2025. Historical debt coverage capacity for YONGHE MED.GR.DL-0000025 across 5 annual periods. Check YONGHE MED.GR.DL-0000025 (L97) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
YONGHE MED.GR.DL-0000025 Cash Flow-to-Debt Ratio by Year (2021–2025)
YONGHE MED.GR.DL-0000025 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for YONGHE MED.GR.DL-0000025. For the full cash flow conversion analysis, see L97 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | €495.53 Million | €914.47 Million | ▲ +140.0% |
| 2024 | 0.23x | €228.62 Million | €1.01 Billion | ▲ +2077.8% |
| 2023 | -0.01x | €-17.15 Million | €1.50 Billion | ▲ +85.9% |
| 2022 | -0.08x | €-108.56 Million | €1.35 Billion | ▼ -127.7% |
| 2021 | 0.29x | €437.28 Million | €1.50 Billion | — |